GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 116 filers reported holding GOSSAMER BIO INC in Q2 2021. The put-call ratio across all filers is 7.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3 | -40.0% | 4 | 0.0% | 0.00% | – |
| Q2 2023 | $5 | 0.0% | 4 | 0.0% | 0.00% | – |
| Q1 2023 | $5 | -100.0% | 4 | -100.0% | 0.00% | – |
| Q4 2022 | $34,670 | -77.6% | 15,977 | +23.6% | 0.00% | -100.0% |
| Q3 2022 | $155,000 | +43.5% | 12,927 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $108,000 | -6.1% | 12,927 | -2.0% | 0.00% | 0.0% |
| Q1 2022 | $115,000 | -2.5% | 13,193 | +26.6% | 0.00% | 0.0% |
| Q4 2021 | $118,000 | -9.9% | 10,421 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $131,000 | +54.1% | 10,421 | 0.0% | 0.00% | – |
| Q2 2021 | $85,000 | -11.5% | 10,421 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $96,000 | -5.0% | 10,421 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $101,000 | -21.7% | 10,421 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $129,000 | -4.4% | 10,421 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $135,000 | +365.5% | 10,421 | +264.8% | 0.00% | – |
| Q1 2020 | $29,000 | -35.6% | 2,857 | 0.0% | 0.00% | – |
| Q4 2019 | $45,000 | – | 2,857 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 4,275,726 | $43,399,000 | 17.96% |
| Boxer Capital, LLC | 2,185,000 | $22,178,000 | 1.51% |
| HHLR ADVISORS, LTD. | 5,911,541 | $60,002,000 | 0.81% |
| Artal Group S.A. | 1,808,968 | $18,361,000 | 0.78% |
| CLOUGH CAPITAL PARTNERS L P | 459,834 | $4,667,000 | 0.46% |
| Spark Investment Management LLC | 39,906 | $405,000 | 0.22% |
| Alyeska Investment Group, L.P. | 476,838 | $4,840,000 | 0.10% |
| Cormorant Asset Management, LP | 198,382 | $2,014,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 36,101 | $366,000 | 0.09% |
| Redmile Group, LLC | 259,700 | $2,636,000 | 0.07% |